Times to reach sensory block T10 (block levels)
| Group | Value | 95% CI |
|---|---|---|
| Group N | 15.25 | ± 1.97 |
| Group C | 10.50 | ± 1.54 |
| Group N/C | 11.25 | ± 2.22 |
Last reviewed · How we verify
Epidural Anesthesia for Transurethral Resection of The Prostate
NA trial testing Epidural injection via Tuohy needle in Epidural Catheter in 60 participants. Completed in 30 December 2010.
| Lead sponsor | Başakşehir Çam & Sakura City Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 2 January 2010 |
| Primary completion | 30 November 2010 |
| Estimated completion | 30 December 2010 |
| Sites | 1 location across Turkey (Türkiye) |
Başakşehir Çam & Sakura City Hospital
Adults 40 to 75, male only, with Epidural Catheter or Epidural Analgesia. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Times to reach sensory block T10 (block levels)
| Group | Value | 95% CI |
|---|---|---|
| Group N | 15.25 | ± 1.97 |
| Group C | 10.50 | ± 1.54 |
| Group N/C | 11.25 | ± 2.22 |
Change in Systolic Blood Pressure from Sedation to 20 Minutes Post-Epidural Block
| Group | Value | 95% CI |
|---|---|---|
| Group N | 126.70 | ± 13.80 |
| Group C | 123.80 | ± 8.61 |
| Group N/C | 126.70 | ± 13.80 |
| Group | Value | 95% CI |
|---|---|---|
| Group N | 116.80 | ± 16.04 |
| Group C | 116.40 | ± 11.99 |
| Group N/C | 121.10 | ± 13.50 |
Dermatomes were converted to numerical scores for statistical analysis: L1 = 1, T12 = 2, T10 = 3, T8 = 4, T6 = 5. Maximum sensory block level was assessed by converting dermatomal levels to numerical scores: L1 = 1, T12 = 2, T10 = 3, T8 = 4, T6 = 5. Higher scores indicate higher (more cephalad) dermatomal levels, which are considered better outcomes in terms of anesthetic spread.
| Group | Value | 95% CI |
|---|---|---|
| Group N | 3.20 | ± 0.52 |
| Group C | 4.10 | ± 0.55 |
| Group N/C | 4.25 | ± 0.54 |
Motor block was assessed using the modified Bromage scale: 0 = No motor block 1. = Partial block (able to move knees and feet) 2. = Moderate block (unable to flex knees, able to move feet) 3. = Complete block (unable to move feet or legs). Scores range from 0 (best outcome, least block) to 3 (worst outcome, complete motor block). Lower scores indicate better functional recovery.
| Group | Value | 95% CI |
|---|---|---|
| Group N | 0.30 | ± 0.66 |
| Group C | 0.60 | ± 1.00 |
| Group N/C | 0.20 | ± 0.62 |
Sensory block regression at 60 minutes post-epidural block was assessed by converting dermatomal levels into numerical scores: L1 = 1, T12 = 2, T10 = 3. This scoring reflects the highest remaining level of sensory block at 60 minutes. Lower scores indicate greater regression of the block, meaning faster recovery. The minimum score is 1 and the maximum is 3.
| Group | Value | 95% CI |
|---|---|---|
| Group N | 2.3 | ± 0.47 |
| Group C | 2.8 | ± 0.86 |
| Group N/C | 2.5 | ± 0.61 |
The aim of this study is to assess the effects of different routes of local anesthetic administration in epidural anesthesia applied to patients undergoing transurethral resection of the prostate (TUR-P). ASA I-III 60 patients were enrolled in the study. Patients were randomized into the following three groups: in Group N (needle), total dose of local anesthetic was administered through the Tuohy needle (n=20), in Group C (catheter), local anesthetic was administered through the epidural catheter (n=20) and in Group N/C (needle/catheter), local anestetic was administered half volume through the needle and half through the catheter (n=20). Hemodynamics, times to reach sensory block T10 (block levels), side effects, patient and surgeon satisfaction were evaluated.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06893809.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing